LISATA THERAP.INC.DL-001 (8NE) — Net Asset Quality Index
LISATA THERAP.INC.DL-001 (8NE) has a Net Asset Quality Index of 72.5% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €11.03 Million minus total liabilities of €3.04 Million yields net assets of €7.99 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read 8NE liabilities breakdown for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
LISATA THERAP.INC.DL-001 Net Asset Quality Index Over Time (2021–2025)
This chart shows how LISATA THERAP.INC.DL-001's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the index stands at 72.5%, representing net assets of €7.99 Million against total assets of €11.03 Million EUR. For live market cap and overall valuation, see how much is LISATA THERAP.INC.DL-001 worth.
Annual Net Asset Quality Index for LISATA THERAP.INC.DL-001 (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for LISATA THERAP.INC.DL-001 from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See LISATA THERAP.INC.DL-001 (8NE) shareholders funds for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 82.3% | €14.60 Million | €17.74 Million | €3.14 Million | ▼ -1.5 pp |
| 2024 | 83.8% | €29.32 Million | €35.00 Million | €5.68 Million | ▼ -3.8 pp |
| 2023 | 87.6% | €47.89 Million | €54.69 Million | €6.80 Million | ▼ -3.2 pp |
| 2022 | 90.8% | €66.32 Million | €73.03 Million | €6.71 Million | ▼ -4.0 pp |
| 2021 | 94.8% | €92.00 Million | €97.01 Million | €5.01 Million | — |